Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to -$0.44.

  • Cross Country Healthcare's EPS (Weighted Average and Diluted) fell 28750.0% to -$0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.15, marking a year-over-year decrease of 28750.0%. This contributed to the annual value of -$0.44 for FY2024, which is 12146.34% down from last year.
  • As of FY2024, Cross Country Healthcare's EPS (Weighted Average and Diluted) stood at -$0.44, which was down 12146.34% from $2.05 recorded in FY2023.
  • Cross Country Healthcare's EPS (Weighted Average and Diluted)'s 5-year high stood at $4.95 during FY2022, with a 5-year trough of -$0.44 in FY2024.
  • Over the past 5 years, Cross Country Healthcare's median EPS (Weighted Average and Diluted) value was $2.05 (recorded in 2023), while the average stood at $1.95.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 108055.56% in 2021, then crashed by 12146.34% in 2024.
  • Over the past 5 years, Cross Country Healthcare's EPS (Weighted Average and Diluted) (Annual) stood at -$0.36 in 2020, then soared by 1080.56% to $3.53 in 2021, then soared by 40.23% to $4.95 in 2022, then crashed by 58.59% to $2.05 in 2023, then plummeted by 121.46% to -$0.44 in 2024.
  • Its EPS (Weighted Average and Diluted) stands at -$0.44 for FY2024, versus $2.05 for FY2023 and $4.95 for FY2022.